Author: Wen, Jianxia; Wang, Ruilin; Liu, Honghong; Tong, Yuling; Wei, Shizhang; Zhou, Xuelin; Li, Haotian; Jing, Manyi; Wang, Min; Zhao, Yanling
Title: Potential therapeutic effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: a mini review Cord-id: 1wis5mqq Document date: 2020_5_19
ID: 1wis5mqq
Snippet: The Corona Virus Disease 2019 (COVID-19) is an acute respiratory infectious disease. At present, COVID-19 has no specific therapeutic drugs, and the main clinical treatment is symptomatic treatment and control of complications. On March 5, 2020, the National Health Commission of the People’s Republic of China issued the Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection (Trial Version 7), which integrated traditional Chinese medicine (TCM) into the treatment
Document: The Corona Virus Disease 2019 (COVID-19) is an acute respiratory infectious disease. At present, COVID-19 has no specific therapeutic drugs, and the main clinical treatment is symptomatic treatment and control of complications. On March 5, 2020, the National Health Commission of the People’s Republic of China issued the Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection (Trial Version 7), which integrated traditional Chinese medicine (TCM) into the treatment of COVID-19. The purpose of this study is to summarize recent studies on the clinic application, pharmacological action, chemical substances and mechanism of Qingwen Baidu Decoction (QBD) on the treatment of various diseases. The results suggested that QBD has multiple pharmacological effects such as anti-inflammation, antiviral, antibacterial, immunomodulatory, antipyretic and so on. It has been used in the treatment of sepsis, epidemic hemorrhagic fever, epidemic cerebrospinal meningitis, infantile pneumonia, sepsis-related encephalopathy, epidemic encephalitis B and other diseases. In addition, this study attempts to explore the possible mechanism of QBD in the prevention and treatment of COVID-19. Through the analysis of the chemical substances, pharmacological action and mechanism of QBD, this paper will provide a reference theoretical basis for the prevention and treatment of COVID-19 by QBD.
Search related documents:
Co phrase search for related documents- abnormal lymphocyte and acute ards respiratory distress syndrome: 1, 2
- abnormal lymphocyte and liver function: 1, 2, 3
- abnormal lymphocyte and liver function abnormal lymphocyte: 1
- action mechanism and acute ali lung injury: 1, 2, 3, 4
- action mechanism and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- action mechanism and liver function: 1
- action mechanism and liver protection: 1
- action mechanism and local inflammation: 1
- action mechanism and lps control: 1
- acute ali lung injury and local inflammation: 1, 2, 3
- acute ali lung injury and lps control: 1, 2, 3
- acute ali lung injury and lps control group: 1, 2
- acute ards respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8
- acute ards respiratory distress syndrome and liver protection: 1
- acute ards respiratory distress syndrome and local inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute ards respiratory distress syndrome and lps control: 1, 2, 3, 4
- acute ards respiratory distress syndrome and lps control group: 1, 2
- acute renal injury and liver function: 1
- local inflammation and lps control: 1
Co phrase search for related documents, hyperlinks ordered by date